SEC Form 4 research
| Issuer | MEI Pharma, Inc. |
|---|---|
| Tickers | MEIP, MSHL, LITS |
| Reporting owners | 56 |
| Officers and directors | 13 |
| Last public filing | 2026-10-26 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-26 | 2025-07-23 | Glover Nicholas | P | 1,000 | $6 | Not reported |
| 2026-10-26 | 2025-07-22 | Glover Nicholas | P | 1,000 | $6.55 | Not reported |
| 2026-10-26 | 2026-10-22 | Glover Nicholas | A | 100,000 | $0 | Not reported |
| 2026-10-26 | 2026-10-22 | File Justin J. | A | 600,000 | $0 | Not reported |
| 2026-10-26 | 2026-10-22 | DRISCOLL FREDERICK W | A | 100,000 | $0 | Not reported |
| 2026-10-26 | 2026-10-22 | Flynn James P | A | 100,000 | $0 | Not reported |
| 2026-10-26 | 2026-10-22 | Riezman Joshua | A | 100,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.